Clinical trial
The Medacta International GMK Sphere Post-Marketing Surveillance Study
NCT02199600 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Medacta International GMK Sphere Post-Marketing Surveillance Study
- Lead sponsor
- Medacta International SA
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 31, 2012
- Completion date
- October 31, 2029
- Enrollment
- 500 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, avascular necrosis, poly-arthritis, rheumatoid arthritis, traumatic arthritis